Introduction: Administration of cholic acid, or its synthetic derivative, 6-alpha-ethyl-
| INTRODUC TI ON
Heart failure is a growing epidemic in the USA, costing ~$35 billion each year. Despite significant advances in its treatments, the 5-year mortality for this disease remains high at ~59% and has remained unchanged over a decade. [1] [2] [3] Current treatments have focused more on rate control and afterload reduction. For outcomes to improve beyond this current status quo, newer strategies must target the heart muscle and enhance cardiomyocyte response to stress.
Bile acids, known merely as detergents aiding in digestion of lipids in the intestine, are now seen as hormones with important regulatory function. [4] [5] [6] Recent observations suggest benefits of modest increases in bile acid levels on host cardiovascular status. A direct correlation has been made between adaptive cardiac metabolic changes and elevated levels of serum bile acids 7 in a rat model of gastric bypass. Ursodeoxychlic acid, a secondary hydrophilic bile acid, has been shown to decrease ER stress in diabetic cardiomyopathy in rats, while secondary hydrophobic bile acid-lithocholic acid has been
shown to attenuate apoptosis in isolated cardiomyocytes. 8 Cholic acid, a primary bile acid in humans, and its semi-synthetic derivative INT-777, 9 have recently been shown to reverse diet-induced obesity, reduce atherosclerosis, and improve metabolic syndrome in mice. [10] [11] [12] These effects are attributed to the ability of cholic acid and INT-777 to activate the membrane bile acid receptor TGR5 13 expressed in the brown adipose tissue, skeletal muscles, and macrophages.
TGR5 has also been found in rodent and human hearts 11, 14 and is amenable to be targeted by bile acids, both in health and in disease.
It has been known for over a century that pathologic elevations of circulating bile acids (~200-300 μmol/L), as seen in liver diseases, are toxic to the heart. [14] [15] [16] [17] [18] However, less is known about the effects of modest elevations of bile acids on myocardial physiology, function, and stress response. The effects of natural endogenous TGR5 agonist, such as cholic acid, or its semi-synthetic derivative and specific TGR5 agonist INT-777 on the heart remains untested.
Also unexplored is the role of the new GPCR-TGR5, which is present in the heart in myocardial health and disease. We hypothesize that upregulation of TGR5 in the heart, achieved by feeding cholic acid or INT-777 supplemented diet, will induce cyto-protectective changes in the heart and enhance its adaptability to physiologic, inotropic, and hemodynamic stress. In contrast, genetic deletion of TGR5 in cardiomyocytes will impair host response to stress.
| MATERIAL S AND ME THODS

| Animals and diet
Six-to 8-week-old male C57BL/6J mice (Jackson Laboratory, Bar
Harbor, ME, USA) were fed with 0.5% cholic acid (CA) supplemented chow (Harlan-Teklad Inc., Madison, WI, USA) for 3 weeks.
Alternatively, mice were fed with the specific TGR5 agonist INT-777 9 (0.025%; provided by Intercept Pharmaceuticals Inc. New York, NY, USA) supplemented chow for 3 weeks. CA and INT-777 doses were calculated based on previously published data. 10, 11 Farnesoid-Xreceptor (FXR) is present in the heart and the vascular endothelial cells and belongs to the family of metabolic nuclear receptor that is responsive to bile acids. 19 To 
| Catecholamine challenge and stress echocardiography
To evaluate the effects of catecholamine on hearts in vivo, mice were anesthetized and challenged with 20 μg/kg of isoprenaline, i.p.
(Sigma-Aldrich; St. Louis, MO, USA). Cardiac parameters were then evaluated pre-and postinjection by echocardiography as described previously. 
| Treadmill exercise protocol and energy expenditure
Mice were challenged with acute submaximal stress in the form of exercise on a treadmill integrated with metabolic chamber (Oxymax Deluxe VO 2 /VCO 2 System Columbus Instruments, Columbus, OH), as previously described.
14,18
| Transverse aortic constriction
To evaluate response to chronic pressure overload induced heart failure, mice underwent transverse aortic constriction (TAC). 18, 22 Tightness of the band was assessed by carotid Doppler 1 week post-TAC. Contractile function was evaluated every 2 weeks by echocardiography for a period of 8 weeks. Findings were then compared between TAC groups and SHAM groups, where mice underwent all procedures except aortic banding.
| Isolation of neonatal mouse cardiomyocytes
Cardiomyocytes were isolated from 1-2-day old C57BL/6 pups (n = 8-10 each) using the isolation kit from Cellutron Life Technologies as described before. 18 Fibroblasts were removed by pre-plating the culture for 90 minutes at 37°C in the complete medium. The cardiomyocytes suspension was then seeded on the plates coated with Sure Coat (1 mL per well) (Cellutron Life Technologies, Baltimore, MD, USA). Twelve-to 16-hour postseeding, the medium was changed to the non-serum medium. All the media were purchased from Cellutron Life Technologies.
| Serum analyses
Sera were collected from either retro-orbital or inferior vena cava 
| Histology
Liver and heart was stained with routine H/E. All histological studies were performed by the Texas Gulf Coast Digestive Disease Center.
| Quantitative real-time PCR (qRTPCR)
RNA quantification of genes was conducted using standard protocol, using probes and primers as previously published. 14 Relative RNA expression was calculated by delta Ct method. Gene expression of target genes was normalized to an internal standard (GAPDH/18S) and the difference expressed as amount of gene expressed per internal standard.
| Immunoblotting
Proteins from whole homogenized hearts and membranes were extracted using standard procedures. 23 Protein concentrations were measured using the Pierce BCA kit (Thermo Scientific, Rockford, IL, USA). After gel electrophoresis and immunoblotting, the gels were analyzed for expression of various proteins with specific antibodies as described before. 14 Equal protein loading was confirmed by α-tubulin/GAPDH (Sigma-Aldrich. St. Louis, MO, USA). Results were analyzed by densitometry (Kodak software) and reported as fold change compared to chow fed hearts.
| Statistical analysis
Data between 2 groups was compared using t test and Mann-Whitney, as specified. Data involving 4 groups (TAC experiments) were compared using ANOVA. All statistical calculations were performed using the PRISM 3.0 software program (Graph-Pad Prism, San Diego, CA, USA). P < 0.05 was selected as the level of significance.
| RE SULTS
| CA feeding induces modest increases in bile acid levels and decreased fat mass in mice
When compared to chow fed mice, whole body weights of mice fed isocaloric 0.5% cholic acid supplemented diet were found to be significantly lower at 1-, 2-and 3-week intervals ( Figure S1A ). Chow fed mice showed ~10% increase, while CA fed mice showed ~5% decrease in body weight when compared to their individual weights at the start of the experiment (Δ in weight from baseline +2.7 ± 0.5 g in chow vs −1 ± 0.6 g in CA group). On analyzing body composition by DEXA, the decrease in body weight in the CA fed mice, was explained by a 15% decrease in body fat content, with no changes in lean mass ( Figure S1B ). Biochemical analysis of the serum shows a modest increase in serum ALT levels ( Figure S1D ), but without any evidence of hepatocyte damage on routine hematoxylin and eosin staining ( Figure S1C ) with CA feeding. There was a mild (3X) increase in circulating bile acid levels, without evidence of cholestasis ( Figure S1D ). There was no mortality or morbidity noted in the CA fed group, in line with observations made by us and others. extra-cellular signal-regulated kinases (ERK 1/2) and PKA enhance cardiomyocyte survival, 25, 26 while certain heat shock proteins, such as HSP-32 (HO-1), HSP 27, HSP 72, confer protection in heart failure. 27 We examined whether bile acids activated these pro-survival kinases and heat shock proteins in the heart and found that hearts of CA fed 
| CA feeding improves chronotropic response to catecholamine and enhances whole body oxygen consumption during exercise
We examined if alterations at the cellular level translated into changes in the physiologic parameters of the heart. Under basal conditions, CA feeding did not affect heart rate, rhythm, contractility, stroke volume, cardiac output, or LV geometry ( Figure S3 ). When mice were injected with a single dose of 20 mcg/kg isoprenaline, both chow fed and CA fed mice showed the expected increase in heart rates from baseline.
However, the chronotropic effect was enhanced in CA fed mice, as evidenced by a significantly higher peak heart rate achieved in the CA fed mice compared to chow ( Figure 2A ). On treadmill challenge, although exhaustion times (time to fatigue) were comparable between the two groups ( Figure 2B ), the CA fed mice had a higher VO2 during exercise ( Figure 3C ). VCO2 was similar, and the respiratory exchange ratio (RER), which is a ratio of VCO2 and VO2, was lower in the CA fed than the chow fed mice ( Figure 2C ).
| CA feeding attenuates transverse aortic constriction (TAC) induced hypertrophy and contractile failure
Short-term activation of AKT, ERK, and PKA as well as expression of heat shock proteins have been associated with improved contractile function in mouse model of pressure overload. We examined whether CA fed hearts were protected from pressure overload induced by transverse aortic constriction (TAC). Both chow fed and CA fed sham mice had comparable ECHO findings throughout the 8 weeks of the experimental period ( Figure 3B ).
TAC induced a decrease in ejection and shortening fractions in both CA and chow fed mice. However, contractile dysfunction in the CA fed group was significantly attenuated at 6-and 8-week interval, when compared to chow fed mice ( Figure 3B ). At necropsy heart weights indexed to both body weight and tibial length increased post TAC, but the increase was attenuated in CA fed mice compared to chow fed mice ( Figure 3C ). CA fed TAC mice also showed an attenuated increase in key markers of LV stress (BNP), pathologic hypertrophy (β-myosin/α-myosin ratio), and fibrosis (TGFβ) when compared to chow fed TAC mice ( Figure 3E ). In addition, we noted that CA fed TAC mice demonstrated modestly (~50%) higher levels of Ser403 phosphorylated (activated) AKT when compared to chow fed TAC mice, suggesting that CA feeding enhanced activation of AKT post-TAC ( Figure 3D ). One of the many downstream targets of AKT is the Forkhead box subfamily O (FOXO) proteins, and particularly FOXO-1, which is involved with modulation of cardiovascular biology and stress response. [28] [29] [30] AKT mediated inhibition of FOXO-1 promotes cell survival. 28 AKT Figure 3D ). A key effect of Akt activation and FOXO1 inhibition is the regulation of PDK4 transcription. PDK4 is a key regulator of myocardial glucose oxidation and determines the metabolic flexibility of the heart. 31,32 Downregulation of PDK4 is essential for adaptability of the heart to withstand stress in the form of injury (ischemic/metabolic/hemodynamic). 33, 34 We found ~50% downregulation of PDK4, a key inhibitor of pyruvate dehydrogenase complex in CA fed TAC hearts ( Figure 3E ).
| INT-777 supplementation is well tolerated in mice
CA has multiple on and off target effects, including effects on FXR.
TGR5 as well as FXR was upregulated in CA fed mouse hearts ( Figure S3 ). In order to test if the molecular and functional effects of CA are secondary through its effects on TGR5, we evaluated whether CA effects can be mimicked using INT-777, a well-studied semisynthetic derivative of CA, which specifically targets TGR5. Mice fed INT-777 supplemented diet for 3 weeks showed comparable weight gain throughout the course of feeding, with similar increases in weights as isocaloric chow fed mice ( Figures S4A and B) . These findings are in line with previously published data from other laboratories. 10, 35 To assess the effects of INT-777 feeding on physiologic parameters of the heart, we performed echocardiography on mice fed INT-777 supplemented diet for 3 weeks and found that basal myocardial function was comparable to chow fed counterparts (Figures S4C). showed a significant downregulation of PDK4.
| INT-
F I G U R E 2 CA improves chronotropic response to catecholamine and enhances whole body oxygen consumption during exercise: (A) shows change in heart rate after intraperitoneal injection of 20 mcg/kg of single dose of isoprenaline. Note significant higher response to catecholamine as evidenced by a higher change in heart rate postisoprenaline. (B) denotes time taken by the mouse to get exhausted on the treadmill. Although the exhaustion times were comparable, there was a significant increase in VO2 (oxygen consumed-a surrogate marker for cardiac output at peak of exercise and decrease in respiratory exchange ratio during peak exercise in CA fed mice compared to chow fed mice (C)). n = 5 per group; Results: Mean ± SD for A and B, SEM for C; *P < 0.05; Stats: t test for A and B. Mann-Whitney across time-points for C 
| INT-777 feeding improves exercise tolerance, chronotropic response to catecholamine, and attenuates transverse aortic constriction (TAC)-induced contractile failure
INT-777 fed mice showed improved exercise tolerance, as evidenced by longer time for exhaustion on the treadmill compared to chow fed controls ( Figure 4C ). On isoprenaline challenge, both chow fed and INT-777 fed mice showed an expected increase in heart rates, shortening fraction and cardiac output from baseline. However, the chronotropic (heart rate) effect of isoprenaline was enhanced in INT-777 fed mice, as evidenced by the significantly higher peak heart rate achieved compared to chow fed mice ( Figure 4D ). Effect of isoprenaline on shortening fractions, ejection fractions, and cardiac F I G U R E 5 Cardiomyocyte specific deletion of TGR5 (CM-TGR5del) in mice, demonstrate exercise intolerance, increased mortality and exaggerated contractile dysfunction in response to TAC, compared to littermates: (i) and (ii) shows proof of TGR5 deletion from the whole heart and adult isolated cardiomyocyte in CM-TGR5del mice. (i) shows knockdown of TGR5 from the whole hearts in CM-TGR5del mice at both RNA and protein level using primers and antibodies used and tested by us before. As this is a cardiomyocyte specific deletion, weak bands seen on PCR and Western blots are a result of presence of TGR5 in the vascular endothelium which is not deleted. A ~60% deletion was achieved from the whole heart when quantified objectively by qRTPCR and densitometry (data not shown When challenged with acute physiologic stress in the form of treadmill exercise, CM-TGR5 del mice ran shorter distance (A) and fatigued (B)
earlier than WT mice. (n = 5/group; Statistics: t test; *P < 0.05; RESULTS: Mean ± SEM). There was no significance in shortening fraction between the two groups on isoprenaline (C). When CM-TGR5del mice were randomized to SHAM or TAC, increased mortality was noted in CM- 
| Direct effects of bile acids on isolated neonatal mouse cardiomyocytes
To assess direct effects of bile acids on the heart, we isolated cardiomyocytes from neonatal pups as described before, 14, 18 and in- was chosen for these experiments because TCA, being a conjugated form of cholic acid does not cross the plasma membrane, and is ideal to study effects of extracellular bile acids on cardiomyocyte biology.
Also, TCA, apart from being a strong TGR5 agonist, 38 is the most predominant circulating conjugated bile acid in mice fed 0.5% CA diet. 11 We have already shown that TCA activates Akt in vitro. exercise, catecholamine, and TAC to evaluate the critical role of TGR5 in the heart. CM-TGR5 del mice ran shorter distance ( Figure 5A) and showed early fatigue ( Figure 5B ) compared to WT littermates. Catecholamine response was similar between the groups ( Figure 5C ). We then randomized WT and CM-TGR5 del mice to TAC/ SHAM. In SHAM animals, ECHO was comparable between WT and CM-TGR5 del mice ( Figure 5E ). However, when challenged with hemodynamic stress, CM-TGR5 del mice showed increased mortality ( Figure 5D ), exaggerated contractile dysfunction ( Figure 5E ) and increased heart weight-to-tibial length ratio ( Figure 5F ) compared to WT littermates, suggesting that absence of TGR5 is detrimental to mice under conditions of pressure overload. The presence of cre recombinase in the hearts did not affect contractility in SHAM or TAC mice (data not shown).
| Effects of INT-747 feeding on mouse hearts
INT-747, specific agonist for FXR, was well tolerated in mice as evidenced by comparative weight gain in both groups ( Figure S6 ). There was no difference in myocardial parameters as evaluated by echocardiography (data not shown), when compared to chow fed mice.
Similarly exercise tolerance on treadmill challenge and heart rate F I G U R E 6 Proposed mechanisms of cardioprotection: Cholic acid and INT-777, acting as TGR5 agonists, activate Akt, ERK and PKA pathways which are cytoprotective and improve myocardial response to stress. Activation of Akt, may inhibit FOXO-1 and suppress PDK4, which improves the metabolic efficiency and adaptability of the heart to catecholamine, exercise, and pressure overload mediated stress response to isoprenaline (20 mcg/kg) were similar in the INT-747 fed mice compared to chow fed counterparts ( Figure S6 ).
| D ISCUSS I ON
In this study, we show for the first time that a modest increment in circulating serum bile acid level, achieved by supplementation of CA in diet, induces cytoprotective changes in the heart characterized by activation of pro-survival kinases and upregulation of heat shock proteins. CA fed hearts showed improved chronotropic response to catecholamine stimulation, and whole body oxygen consumption during exercise, and more importantly attenuated contractile failure and hypertrophy in the TAC model of heart failure. Our study also
shows that cholic acid supplementation enhances activation of AKT, inhibition of FOXO-1 when exposed to pressure overload and induces downregulation of PDK4, a key inactivator of pyruvate dehydrogenase complex, and a determinant of metabolic flexibility in the heart.
The critical role of TGR5 present in the heart is emphasized by cardio- Short-term modest elevations of bile acid levels, achieved by cholic acid supplementation, alter the molecular makeup of the heart and its response to stress. At a protein level, we found activation of three classic pro-survival kinases, Akt, PKA, and ERK.
These kinases have a special significance in the heart, as they are collectively known as Reperfusion Injury Salvage Kinases (RISK), and are now being pharmacologically activated to preserve cardiomyocyte function and prevent cell death in ischemia and reperfusion. 26, 39, 40 At the RNA level, we found in cholic acid fed mice an upregulation of heat shock proteins 32 (HO-1), 27, 72, and 90, and eNOS, in the heart, all of which are known to be cardioprotective. 27 These changes at the molecular level translated to enhanced host response to myocardial stress in the form of exercise, inotropy, and pressure overload. CA fed mice, albeit showing comparable times to exhaustion, had a higher rate of oxygen consumption (VO2)-a surrogate marker for cardiac output than their chow fed counterparts. The most significant response to priming of the heart with CA feeding was seen when mice were subjected to pressure overload by aortic banding. In this well-established model of heart failure, we found that the CA feeding delayed the onset of contractile failure.
Collectively this introduces cholic acid as a novel endogenous metabolite that has the potential to induce preconditioning of the heart.
An important finding of our study, which could be potentially mechanistic is the effect of CA feeding on the Akt-FOXO-1 pathway in the heart. A well-studied mechanism behind short-term AKT activation and cardiomyocyte survival is its effect on regulating translocation and activity of the forkhead transcription factors (FOXO) subfamily, which includes FOXO-1. FOXO-1 is directly phosphorylated at 35 all of which improve the overall cardiovascular status of the host.
Mice tolerated INT-777 supplemented diet. Remarkably, 3 weeks of feeding induced a robust activation of Akt-FOXO-1-PDK4 pathway.
INT-777 enhanced mouse ability to exercise on a treadmill, and similar to CA fed mice, INT-777 primed hearts demonstrated increased sensitivity to catecholamines and showed an attenuated response to pressure overload both at a functional and molecular level. which is currently being tested in preclinical studies to cure metabolic syndrome and diabesity could be an interesting agent to be tested in various models of heart failure, with considerable clinical potential.
The critical role for TGR5 in myocardial physiology and adaptation to stress is perhaps best highlighted by our findings in mice with constitutive deletion of TGR5 in cardiomyocytes. In the CM-TGR5 del hearts, because the deletion is driven by alpha myosin cre, TGR5 is still expressed in the vascular endothelium. Nevertheless, genetic lack of TGR5 in cardiomyocytes significantly and surprisingly impaired myocardial ability to adapt to the three stressors tested.
These studies now introduce a new GPCR that may be pharmacologically or genetically targeted for a healthier heart. TGR5 can potentially be easily targeted not only by bile acids, but also by a wide array of readily available synthetic analogues and natural products 38, 46 to activate the Akt signaling pathway, to modulate myocardial expression of PDK4 and optimize myocardial glucose metabolism to benefit patients suffering from different forms of heart diseases.
Our previous studies have shown that mice with pathologically high circulating bile acid levels have abnormal heart rate, rhythm, contractility, and catecholamine resistance, along with exercise intolerance. High levels of bile acids disrupt fatty acid oxidation and impair ability of a cholestatic myocardium to adapt to stress, a concept we termed "cholecardia". 18 In this report, we observe that modest increases in bile acids are cardio protective. These diametric opposite observations are intriguing and the mechanisms need to be elucidated and will be the next steps in our research.
It is, however, worth speculating why there are such contrasting effects. Bile acids are signaling metabolites with effects beyond the hepatobiliary tract. As with all metabolites, dose determines its toxicity, and we believe that levels of circulating bile acids determine cardio-toxic effects versus cardio-protective effects.
Bile acids are known to be ligands for TGR5 as well as muscarinic M2 cholinergic receptors, (M2), both of which are present on the cardiomyocyte cell membrane. 12, 14, 51 TGR5 is a Gαs (stimulatory) protein coupled receptor, while M2 receptors are Gi (inhibitory)
receptors. 12, 51 These receptors have contrasting effects on signaling and function. It has already been shown that at toxic concentrations, bile acids stimulate the M2 receptors, which cause negative effects on myocardial contractility and heart rate. 52 A study recently published by the same group shows that bile acid effect on TGR5 and M2 is dose and species (type of bile acid) dependent, whereby TGR5 effects are seen at lower concentration, whereas muscarinic effects are seen at higher concentrations. 12 This study further adds credence to the theory that dose determines cardio-toxicity vs. cardio-protection. It is our speculation, that cardio-protective effects are mediated by functional activation of TGR5, induced by modest elevation in circulating bile acid levels, and that that low dose of bile acids improves metabolic flexibility through TGR5 mediated downregulation of PDK4 by activating the Akt-FOXO-1 pathway. In reverse, cardio-toxic effects seen with bile acid overload are potentially mediated by M2
receptors. Bile acid excess leads to downregulation of PGC1α and impaired fatty acid metabolism and loss of myocardial adaptive capacity to stress. We would like to acknowledge that these are merely observations and associations and do not show cause and effect. This major limitation will need to be addressed by exhaustive studies to dissect the mechanisms to convincingly answer this important question.
In conclusion, we propose a unique role for TGR5 receptor and its agonists in enhancing adaptive responses of the heart to stress.
Future studies should test TGR5 agonists as rational adjuncts to current therapy to prevent rapid progression of heart failure.
AUTH O R CO NTR I B UTI O N S
MSD, SJK, DDM, HT, and DJP conceived of the presented idea; ZE and MSD conducted the actual experiments and wrote the manuscript; ST, HT, LA, and DDM gave scientific help, guidance and proof read the manuscript. All authors discussed the results and contributed to the final manuscript.
CO N FLI C T O F I NTE R E S T
The authors declare no conflict of interest.
O RCI D
Moreshwar S. Desai http://orcid.org/0000-0001-8921-6067
